Pfizer For Children

US health authorities on Saturday cleared the Pfizer and Moderna Covid-19 vaccines for children aged five and younger, in a move President Joe Biden greeted as a "monumental step" in the fight against the virus.

The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.

The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.

Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.

Pfizer and BioNTech will soon ask US regulators for emergency authorization for a Covid-19 vaccine for children aged five and under, US media reported Tuesday.

US health authorities on Monday approved Pfizer's Covid-19 booster shot for children as young as 12, and reduced the wait time between initial vaccination and an extra dose from six months to five, for all ages.

British regulators on Wednesday approved Pfizer's Covid-19 vaccine for use in children aged five to 11, as the country reported more than 100,000 new daily cases for the first time as Omicron surged.

Pfizer announced Friday that it wants to test a third dose of the Covid-19 vaccine in the under-fives, as the low dosage such small children can handle may not offer the same protection that older children enjoy from just two shots.

New Zealand's health regulator Medsafe has granted provisional approval for the Pfizer Inc COVID-19 vaccine for children aged 5 to 11 years old, the health ministry said in a statement.

The EU's main Covid vaccine provider, BioNTech/Pfizer, will have jabs available for children in the bloc in two weeks' time, European Commission chief Ursula von der Leyen said Wednesday.

The EU's drug regulator approved Pfizer's coronavirus jab for children aged 5 to 11 on Thursday, clearing the way for the vaccination in a cohort where the virus is rapidly spreading.

Canada on Friday became the latest country to authorize the Pfizer-BioNTech Covid-19 vaccine for children aged between five and 11-years-old, according to an official statement.

The United States can now start giving children aged 5-11 the Pfizer-BioNtech Covid vaccine, US health authorities said Tuesday as they gave final approval to this new phase of fighting the pandemic.

The United States on Friday authorised the Pfizer Covid vaccine for children aged 5 to 11, paving the way for 28 million young Americans to soon get immunized.

A medical panel of US government advisors endorsed the Pfizer Covid-19 vaccine in five-to-11-year-olds Tuesday, paving the way for younger children to get their shots within weeks.

US health authorities on Saturday cleared the Pfizer and Moderna Covid-19 vaccines for children aged five and younger, in a move President Joe Biden greeted as a "monumental step" in the fight against the virus.

The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.

The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.

Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.

Pfizer and BioNTech will soon ask US regulators for emergency authorization for a Covid-19 vaccine for children aged five and under, US media reported Tuesday.

US health authorities on Monday approved Pfizer's Covid-19 booster shot for children as young as 12, and reduced the wait time between initial vaccination and an extra dose from six months to five, for all ages.

British regulators on Wednesday approved Pfizer's Covid-19 vaccine for use in children aged five to 11, as the country reported more than 100,000 new daily cases for the first time as Omicron surged.

Pfizer announced Friday that it wants to test a third dose of the Covid-19 vaccine in the under-fives, as the low dosage such small children can handle may not offer the same protection that older children enjoy from just two shots.

New Zealand's health regulator Medsafe has granted provisional approval for the Pfizer Inc COVID-19 vaccine for children aged 5 to 11 years old, the health ministry said in a statement.

The EU's main Covid vaccine provider, BioNTech/Pfizer, will have jabs available for children in the bloc in two weeks' time, European Commission chief Ursula von der Leyen said Wednesday.

The EU's drug regulator approved Pfizer's coronavirus jab for children aged 5 to 11 on Thursday, clearing the way for the vaccination in a cohort where the virus is rapidly spreading.

Canada on Friday became the latest country to authorize the Pfizer-BioNTech Covid-19 vaccine for children aged between five and 11-years-old, according to an official statement.

The United States can now start giving children aged 5-11 the Pfizer-BioNtech Covid vaccine, US health authorities said Tuesday as they gave final approval to this new phase of fighting the pandemic.

The United States on Friday authorised the Pfizer Covid vaccine for children aged 5 to 11, paving the way for 28 million young Americans to soon get immunized.

A medical panel of US government advisors endorsed the Pfizer Covid-19 vaccine in five-to-11-year-olds Tuesday, paving the way for younger children to get their shots within weeks.